Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Patients With Nausea
This study is ongoing, but not recruiting participants.
Study NCT01556932 Information provided by Virginia Commonwealth University
First Received on March 13, 2012. Last Updated on May 24, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nausea and Vomiting
Additional conditions recognized in this trial
Nausea
Vomiting
More general conditions related to this trial
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
lorazepam
diphenhydramine hydrochloride
haloperidol
placebo
Additional drug interventions recognized in this trial
Diphenhydramine
Haloperidol decanoate
Promethazine
More general drug interventions related to this trial
Anesthetics
Anesthetics, Local
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Dyskinesia Agents
Anticonvulsants
Antiemetics
Antipruritics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dermatologic Agents
Dopamine Agents
Dopamine Antagonists
GABA Agents
GABA Modulators
Gastrointestinal Agents
Histamine Agents
Histamine Antagonists
Histamine H1 Antagonists
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Virginia Commonwealth University
National Cancer Institute (NCI)
Back to top of Main Content
